Network meta-analysis shows adjunctive therapies do not improve hard outcomes in ST-elevation myocardial infarction compared to conventional therapy, suggesting limitations in specific endpoints.
Adjunctive IC treatments during primary PCI do not influence hard clinical outcomes compared to conventional therapy within a mean 8-month follow-up, although several of them lead to an improvement in surrogate endpoints of CMVO.
No takes yet. Share an insight, caveat, or question.
Laborante et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: